DIVA Laboratories, Ltd. (TPEX:4153)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
32.00
-0.15 (-0.47%)
Apr 20, 2026, 1:24 PM CST

DIVA Laboratories Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
868.84862.32893.84949.2712.23
Revenue Growth (YoY)
0.76%-3.53%-5.83%33.27%-3.35%
Cost of Revenue
604.7602.14643.07683.07530.64
Gross Profit
264.14260.18250.77266.13181.6
Selling, General & Admin
82.3185.7185.0197.788.18
Research & Development
72.4671.969.1682.6269.52
Other Operating Expenses
-0.540.28-2.170.46-0.18
Operating Expenses
161.89149.01158.62181.3158.99
Operating Income
102.26111.1792.1584.8322.6
Interest Expense
-0.24-0.21-0.33-0.2-0.11
Interest & Investment Income
6.185.84.370.760.53
Earnings From Equity Investments
1.671.71-7.16-1.032.16
Currency Exchange Gain (Loss)
--1.28-17.07-2.14-11.16
Other Non Operating Income (Expenses)
-1.114.96.668.3911.15
EBT Excluding Unusual Items
108.75122.0978.6390.6225.18
Impairment of Goodwill
----5.18-
Gain (Loss) on Sale of Investments
--6.149.21-17.340.44
Gain (Loss) on Sale of Assets
---0.070.932.85
Asset Writedown
----1.38-
Pretax Income
108.75115.9587.7767.6428.47
Income Tax Expense
18.2122.2914.1517.986.61
Net Income
90.5493.6673.6249.6621.86
Net Income to Common
90.5493.6673.6249.6621.86
Net Income Growth
-3.33%27.23%48.24%127.23%25.47%
Shares Outstanding (Basic)
5959595959
Shares Outstanding (Diluted)
5959595959
Shares Change (YoY)
-0.22%0.03%0.13%0.07%-11.69%
EPS (Basic)
1.541.601.250.850.37
EPS (Diluted)
1.541.591.250.840.37
EPS Growth
-3.15%27.20%48.81%127.03%42.31%
Free Cash Flow
19.89121.63245.4362.84-23.53
Free Cash Flow Per Share
0.342.064.171.07-0.40
Dividend Per Share
-2.0001.2501.0000.370
Dividend Growth
-60.00%25.00%170.27%42.31%
Gross Margin
30.40%30.17%28.06%28.04%25.50%
Operating Margin
11.77%12.89%10.31%8.94%3.17%
Profit Margin
10.42%10.86%8.24%5.23%3.07%
Free Cash Flow Margin
2.29%14.11%27.46%6.62%-3.30%
EBITDA
111.58118.67100.3293.0634.05
EBITDA Margin
12.84%13.76%11.22%9.80%4.78%
D&A For EBITDA
9.327.58.178.2311.44
EBIT
102.26111.1792.1584.8322.6
EBIT Margin
11.77%12.89%10.31%8.94%3.17%
Effective Tax Rate
16.74%19.22%16.12%26.58%23.23%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.